Matches in Wikidata for { <http://www.wikidata.org/entity/Q65470453> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q65470453 description "clinical trial" @default.
- Q65470453 description "ensayu clínicu" @default.
- Q65470453 description "klinisch onderzoek" @default.
- Q65470453 description "клінічне випробування" @default.
- Q65470453 description "կլինիկական փորձարկում" @default.
- Q65470453 name "Omalizumab Use and Asthma-Related Quality of Life in Patients With Severe Persistent Allergic Asthma" @default.
- Q65470453 name "Omalizumab Use and Asthma-Related Quality of Life in Patients With Severe Persistent Allergic Asthma" @default.
- Q65470453 type Item @default.
- Q65470453 label "Omalizumab Use and Asthma-Related Quality of Life in Patients With Severe Persistent Allergic Asthma" @default.
- Q65470453 label "Omalizumab Use and Asthma-Related Quality of Life in Patients With Severe Persistent Allergic Asthma" @default.
- Q65470453 prefLabel "Omalizumab Use and Asthma-Related Quality of Life in Patients With Severe Persistent Allergic Asthma" @default.
- Q65470453 prefLabel "Omalizumab Use and Asthma-Related Quality of Life in Patients With Severe Persistent Allergic Asthma" @default.
- Q65470453 P1050 Q65470453-4A95DFB4-781F-4CF3-A3F5-7F5F56701EB5 @default.
- Q65470453 P1132 Q65470453-4C68E152-DC01-4724-AC5B-984DE2B1F573 @default.
- Q65470453 P1476 Q65470453-692B310B-27FC-402F-9CD4-DD683B4409EC @default.
- Q65470453 P17 Q65470453-41CE81E0-5C98-4B6F-8346-C50040ACFBD9 @default.
- Q65470453 P2899 Q65470453-FD4D7194-6DF4-49E9-A22C-6AD83B104812 @default.
- Q65470453 P3098 Q65470453-3E0CD527-9950-4BCA-81BF-3EBDE33D99AA @default.
- Q65470453 P31 Q65470453-761831B2-3EC6-41E1-9F98-F84A1E228E2C @default.
- Q65470453 P4135 Q65470453-1A0CC56E-2B51-446E-B321-754274896F10 @default.
- Q65470453 P4844 Q65470453-65BF2C5D-C405-4852-8C64-89716CF7DC84 @default.
- Q65470453 P4844 Q65470453-D65A7B9B-1A5D-4517-A6A4-2EED9107142E @default.
- Q65470453 P4844 Q65470453-E466A78C-0E8B-45E8-8754-0676AEC36409 @default.
- Q65470453 P580 Q65470453-E4A44043-DB57-4007-AD5E-79DDF5D02240 @default.
- Q65470453 P582 Q65470453-7EA2188C-14C3-40D6-8E33-53DA84BEAE69 @default.
- Q65470453 P6099 Q65470453-5016BA99-8EEA-4EA7-9340-30DC9F630B4F @default.
- Q65470453 P6153 Q65470453-29725D51-FF8F-46FB-8531-2471F45E9A14 @default.
- Q65470453 P8363 Q65470453-03C419AE-661D-465E-87A4-DEA4ACB44D91 @default.
- Q65470453 P1050 Q35869 @default.
- Q65470453 P1132 "+116" @default.
- Q65470453 P1476 "A Randomized, Open-label, Multicenter Study to Evaluate the Effect of Xolair (Omalizumab) as Add-on Therapy to Inhaled Corticosteroid + Long-Acting Beta Agonist in Fixed or Flexible Dosing Compared to Isolated Inhaled Corticosteroid + Long-Acting Beta Agonist in Fixed or Flexible Dosing in the Asthma-Related Quality of Life in Patients With Severe Persistent Allergic Asthma" @default.
- Q65470453 P17 Q155 @default.
- Q65470453 P2899 "+12" @default.
- Q65470453 P3098 "NCT00567476" @default.
- Q65470453 P31 Q30612 @default.
- Q65470453 P4135 "+75" @default.
- Q65470453 P4844 Q186242 @default.
- Q65470453 P4844 Q424340 @default.
- Q65470453 P4844 Q7279006 @default.
- Q65470453 P580 "2007-11-01T00:00:00Z" @default.
- Q65470453 P582 "2010-04-01T00:00:00Z" @default.
- Q65470453 P6099 Q42825046 @default.
- Q65470453 P6153 Q507154 @default.
- Q65470453 P8363 Q78089383 @default.